Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 408

1.

A rare case of multi-focal human TB after BCG instillation for non-muscle-invasive bladder cancer.

Riccardi N, Ferrarese M, Castellotti P, Mazzola E, Sozzi F, Rigatti P, Vanzulli A, Sotgiu G, Codecasa L.

Urologia. 2019 Jul 4:391560319860396. doi: 10.1177/0391560319860396. [Epub ahead of print]

PMID:
31271544
2.

Corrigendum re "Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non-muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study" [Eur Urol 2012;62:797-802].

Colombo R, Rocchini L, Suardi N, Benigni F, Colciago G, Bettiga A, Pellucchi F, Maccagnano C, Briganti A, Salonia A, Rigatti P, Montorsi F.

Eur Urol. 2019 Mar;75(3):e81. doi: 10.1016/j.eururo.2018.09.012. Epub 2018 Nov 5. No abstract available.

PMID:
30409675
3.

Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium.

Nini A, Capitanio U, Larcher A, Dell'Oglio P, Dehò F, Suardi N, Muttin F, Carenzi C, Freschi M, Lucianò R, La Croce G, Briganti A, Colombo R, Salonia A, Castiglioni A, Rigatti P, Montorsi F, Bertini R.

Eur Urol. 2018 May;73(5):793-799. doi: 10.1016/j.eururo.2017.08.019. Epub 2017 Sep 13.

PMID:
28917595
4.

Intraoperative Retrograde Perfusion Sphincterometry to Evaluate Efficacy of Autologous Vas Deferens 6-Branch Suburethral Sling to Properly Restore Sphincteric Apparatus During Robot-Assisted Radical Prostatectomy.

Cestari A, Soranna D, Zanni G, Zambon A, Zanoni M, Sangalli M, Ghezzi M, Fabbri F, Sozzi F, Dell'Acqua V, Rigatti P.

J Endourol. 2017 Sep;31(9):878-885. doi: 10.1089/end.2017.0250. Epub 2017 Jul 31.

PMID:
28665139
5.

Simple vs six-branches autologous suburethral sling during robot-assisted radical prostatectomy to improve early urinary continence recovery: prospective randomized study.

Cestari A, Ferrari M, Sangalli M, Zanoni M, Ghezzi M, Fabbri F, Sozzi F, Lolli C, Dell'Acqua V, Rigatti P.

J Robot Surg. 2017 Dec;11(4):415-421. doi: 10.1007/s11701-017-0672-6. Epub 2017 Jan 11.

PMID:
28078523
6.

Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up.

Gandaglia G, Fossati N, Stabile A, Bandini M, Rigatti P, Montorsi F, Briganti A.

Eur Urol. 2017 Aug;72(2):289-292. doi: 10.1016/j.eururo.2016.08.040. Epub 2016 Aug 27.

PMID:
27574820
7.

(18)F-FACBC (anti1-amino-3-(18)F-fluorocyclobutane-1-carboxylic acid) versus (11)C-choline PET/CT in prostate cancer relapse: results of a prospective trial.

Nanni C, Zanoni L, Pultrone C, Schiavina R, Brunocilla E, Lodi F, Malizia C, Ferrari M, Rigatti P, Fonti C, Martorana G, Fanti S.

Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1601-10. doi: 10.1007/s00259-016-3329-1. Epub 2016 Mar 10.

PMID:
26960562
8.

Side docking of the da Vinci robotic system for radical prostatectomy: advantages over traditional docking.

Cestari A, Ferrari M, Zanoni M, Sangalli M, Ghezzi M, Fabbri F, Sozzi F, Rigatti P.

J Robot Surg. 2015 Sep;9(3):243-7. doi: 10.1007/s11701-015-0523-2. Epub 2015 Jul 24.

PMID:
26531205
9.

Incidental retroperitoneal paraganglioma in patient candidate to radical prostatectomy: Concurrent surgical treatments by robotic approach.

Ferrari M, Sangalli M, Zanoni M, Ghezzi M, Fabbri F, Sozzi F, Rigatti P, Cestari A.

Can Urol Assoc J. 2015 Jul-Aug;9(7-8):E539-41. doi: 10.5489/cuaj.2501.

10.

Retropubic Intracorporeal Placement of a Suburethral Autologous Sling During Robot-Assisted Radical Prostatectomy to Improve Early Urinary Continence Recovery: Preliminary Data.

Cestari A, Ferrari M, Ghezzi M, Sangalli M, Zanoni M, Fabbri F, Sozzi F, Lolli C, Dell'Acqua V, Rigatti P.

J Endourol. 2015 Dec;29(12):1379-85. doi: 10.1089/end.2015.0292. Epub 2015 Sep 8.

PMID:
26131781
11.

Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients.

Colombo R, Pellucchi F, Moschini M, Gallina A, Bertini R, Salonia A, Rigatti P, Montorsi F.

World J Urol. 2015 Oct;33(10):1389-95. doi: 10.1007/s00345-015-1482-y. Epub 2015 Jan 11.

PMID:
25577131
12.

Onset of hydronephrosis and lower urinary tract symptoms in a previously healthy young man: Phyllodes tumour of the prostate as a potential diagnosis.

Ferrari M, Capitanio U, Rizzo N, Freschi M, Montorsi F, Rigatti P.

Can Urol Assoc J. 2014 Jul;8(7-8):E561-3. doi: 10.5489/cuaj.1984.

13.

Effects of Difaprost® on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment.

Suardi N, Gandaglia G, Nini A, Montorsi F, Pellucchi F, Agostini A, Rigatti P.

Minerva Urol Nefrol. 2014 Jun;66(2):119-25.

PMID:
24988203
14.

Sexual function in adult life following Passerini-Glazel feminizing genitoplasty in patients with congenital adrenal hyperplasia.

Lesma A, Bocciardi A, Corti S, Chiumello G, Rigatti P, Montorsi F.

J Urol. 2014 Jan;191(1):206-11. doi: 10.1016/j.juro.2013.07.097. Epub 2013 Aug 6.

PMID:
23933397
15.

The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.

Abdollah F, Suardi N, Capitanio U, Matloob R, Fossati N, Castiglione F, Di Trapani E, Di Trapani D, Russo A, Carenzi C, Montorsi F, Rigatti P, Bertini R.

Urol Oncol. 2014 Jan;32(1):43.e9-16. doi: 10.1016/j.urolonc.2013.05.006. Epub 2013 Aug 2.

PMID:
23911684
16.

Development of functionally patent lymphatic meshes in postsurgical long-term resolution of peripheral secondary lymphedema.

Mukenge S, Negrini D, Catena M, Ratti F, Dosio F, Paesano P, Rigatti P, Ferla G.

J Vasc Surg Venous Lymphat Disord. 2013 Jul;1(3):280-8. doi: 10.1016/j.jvsv.2012.09.008. Epub 2013 Feb 15.

PMID:
26992588
17.

Spatial distribution of positive cores improves the selection of patients with low-risk prostate cancer as candidates for active surveillance.

Abdollah F, Suardi N, Capitanio U, Gallina A, Sun M, Villa L, Scattoni V, Bianchi M, Tutolo M, Fossati N, Karakiewicz P, Rigatti P, Montorsi F, Briganti A.

BJU Int. 2013 Aug;112(4):E234-42. doi: 10.1111/bju.12152. Epub 2013 Jun 7.

18.

Kidney endometriosis.

Maccagnano C, Freschi M, Ghezzi M, Rocchini L, Pellucchi F, Rigatti P, Montorsi F, Colombo R.

Minerva Urol Nefrol. 2013 Jun;65(2):157-9. No abstract available.

PMID:
23703102
19.

Ureteral endometriosis: proposal for a diagnostic and therapeutic algorithm with a review of the literature.

Maccagnano C, Pellucchi F, Rocchini L, Ghezzi M, Scattoni V, Montorsi F, Rigatti P, Colombo R.

Urol Int. 2013;91(1):1-9. doi: 10.1159/000345140. Epub 2013 Jan 22. Review.

20.

Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center.

Abdollah F, Suardi N, Gallina A, Bianchi M, Tutolo M, Passoni N, Fossati N, Sun M, dell'Oglio P, Salonia A, Karakiewicz PI, Rigatti P, Montorsi F, Briganti A.

Ann Oncol. 2013 Jun;24(6):1459-66. doi: 10.1093/annonc/mdt120. Epub 2013 Mar 18.

PMID:
23508825
21.

Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection.

Passoni NM, Abdollah F, Suardi N, Gallina A, Bianchi M, Tutolo M, Fossati N, Gandaglia G, Salonia A, Freschi M, Rigatti P, Montorsi F, Briganti A.

Urol Oncol. 2014 Jan;32(1):29.e21-8. doi: 10.1016/j.urolonc.2012.10.009. Epub 2013 Mar 13.

PMID:
23490908
22.

Robotic assisted radical prostatectomy in morbidly obese patients: how to create a cost-effective adequate optical trocar.

Cestari A, Sangalli M, Buffi NM, Lazzeri M, Larcher A, Scapaticci E, Lughezzani G, Fabbri F, Rigatti P, Guazzoni G.

J Robot Surg. 2013 Mar;7(1):47-51. doi: 10.1007/s11701-012-0344-5. Epub 2012 Mar 8.

PMID:
27000892
23.

Effects by silodosin on the partially obstructed rat ureter in vivo and on human and rat isolated ureters.

Villa L, Buono R, Fossati N, Rigatti P, Montorsi F, Benigni F, Hedlund P.

Br J Pharmacol. 2013 May;169(1):230-8. doi: 10.1111/bph.12123.

24.

Inhibition of phosphodiesterase 4 enhances clitoral and vaginal blood flow responses to dorsal clitoral nerve stimulation or PGE1 in anesthetized female rats.

Castiglione F, Bergamini A, Russo A, La Croce G, Castagna G, Colciago G, Salonia A, Rigatti P, Montorsi F, Hedlund P.

J Sex Med. 2013 Apr;10(4):939-50. doi: 10.1111/jsm.12058. Epub 2013 Jan 24.

PMID:
23347325
25.

A novel tool to assess the risk of urinary incontinence after nerve-sparing radical prostatectomy.

Abdollah F, Sun M, Suardi N, Gallina A, Tutolo M, Passoni N, Bianchi M, Salonia A, Colombo R, Rigatti P, Karakiewicz PI, Montorsi F, Briganti A.

BJU Int. 2013 May;111(6):905-13. doi: 10.1111/j.1464-410X.2012.11560.x. Epub 2013 Jan 17.

26.

Circulating sex steroids and prostate cancer: introducing the time-dependency theory.

Salonia A, Abdollah F, Capitanio U, Suardi N, Gallina A, Castagna G, Clementi MC, Briganti A, Rigatti P, Montorsi F.

World J Urol. 2013 Apr;31(2):267-73. doi: 10.1007/s00345-012-1009-8. Epub 2013 Jan 3.

PMID:
23283410
27.

Reply from Authors re: Ching-Shwun Lin, Tom F. Lue. Adipose-derived Stem Cells for the Treatment of Peyronie's Disease? Eur Urol 2013;63:561-2: Xenogeneic Adipose Stem Cell Treatment in a Rat Model of Peyronie's Disease.

Castiglione F, Hedlund P, Van der Aa F, Bivalacqua TJ, Rigatti P, Van Poppel H, Montorsi F, De Ridder D, Albersen M.

Eur Urol. 2013 Mar;63(3):563-4. doi: 10.1016/j.eururo.2012.12.002. Epub 2012 Dec 13. No abstract available.

PMID:
23265388
28.

Optimizing postoperative sexual function after radical prostatectomy.

Tutolo M, Briganti A, Suardi N, Gallina A, Abdollah F, Capitanio U, Bianchi M, Passoni N, Nini A, Fossati N, Rigatti P, Montorsi F.

Ther Adv Urol. 2012 Dec;4(6):347-65. doi: 10.1177/1756287212450063.

29.

Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy.

Capitanio U, Abdollah F, Matloob R, Salonia A, Suardi N, Briganti A, Carenzi C, Rigatti P, Montorsi F, Bertini R.

Int J Urol. 2013 Jun;20(6):572-9. doi: 10.1111/iju.12004. Epub 2012 Nov 19.

30.

Impact of the introduction of a robotic training programme on prostate cancer stage migration at a single tertiary referral centre.

Briganti A, Bianchi M, Sun M, Suardi N, Gallina A, Abdollah F, Bertini R, Colombo R, Girolamo VD, Salonia A, Scattoni V, Karakiewicz PI, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2013 Jun;111(8):1222-30. doi: 10.1111/j.1464-410X.2012.11464.x. Epub 2012 Nov 13.

31.

Selecting the optimal candidate for adjuvant radiotherapy after radical prostatectomy for prostate cancer: a long-term survival analysis.

Abdollah F, Suardi N, Cozzarini C, Gallina A, Capitanio U, Bianchi M, Sun M, Fossati N, Passoni NM, Fiorino C, Di Muzio N, Karakiewicz PI, Rigatti P, Montorsi F, Briganti A.

Eur Urol. 2013 Jun;63(6):998-1008. doi: 10.1016/j.eururo.2012.10.036. Epub 2012 Oct 26.

PMID:
23122664
32.

Reply to Manish Garg, Apul Goel and Jai Prakash's letter to the editor re: Renzo Colombo, Lorenzo Rocchini, Nazareno Suardi, et al. Neoadjuvant short-term intensive intravesical mitomycin C regimen compared with weekly schedule for low-grade recurrent non-muscle-invasive bladder cancer: preliminary results of a randomised phase 2 study. Eur Urol 2012;62:797-802.

Colombo R, Rocchini L, Suardi N, Benigni F, Colciago G, Bettiga A, Pellucchi F, Maccagnano C, Briganti A, Salonia A, Rigatti P, Montorsi F.

Eur Urol. 2013 Jan;63(1):e7-8. doi: 10.1016/j.eururo.2012.09.029. Epub 2012 Sep 23. No abstract available.

PMID:
23092542
33.

Delay in seeking medical help in patients with new-onset erectile dysfunction remained high over and despite the PDE5 era--an ecological study.

Salonia A, Ferrari M, Saccà A, Pellucchi F, Castagna G, Clementi MC, Matloob R, Briganti A, Rigatti P, Montorsi F.

J Sex Med. 2012 Dec;9(12):3239-46. doi: 10.1111/j.1743-6109.2012.02953.x. Epub 2012 Oct 11.

PMID:
23057479
34.

Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease.

Castiglione F, Hedlund P, Van der Aa F, Bivalacqua TJ, Rigatti P, Van Poppel H, Montorsi F, De Ridder D, Albersen M.

Eur Urol. 2013 Mar;63(3):551-60. doi: 10.1016/j.eururo.2012.09.034. Epub 2012 Sep 24. Erratum in: Eur Urol. 2013 Jul;64(1):e21.

35.

The number of cores taken in patients diagnosed with a single microfocus at initial biopsy is a major predictor of insignificant prostate cancer.

Villa L, Capitanio U, Briganti A, Abdollah F, Suardi N, Salonia A, Gallina A, Freschi M, Russo A, Castiglione F, Bianchi M, Rigatti P, Montorsi F, Scattoni V.

J Urol. 2013 Mar;189(3):854-9. doi: 10.1016/j.juro.2012.09.100. Epub 2012 Sep 25.

PMID:
23022004
36.

Clinical and diagnostic assessment for therapeutic decisions in prostate cancer.

Passoni NM, Di Trapani E, Suardi N, Gallina A, Abdollah F, Bianchi M, Picchio M, Giovacchini G, Messa C, Rigatti P, Montorsi F, Briganti A.

Q J Nucl Med Mol Imaging. 2012 Aug;56(4):321-30. Review.

37.

Postoperative phosphodiesterase type 5 inhibitor administration increases the rate of urinary continence recovery after bilateral nerve-sparing radical prostatectomy.

Gandaglia G, Albersen M, Suardi N, Gallina A, Abdollah F, Castiglione F, Capitanio U, Salonia A, Rigatti P, Hedlund P, Montorsi F, Briganti A.

Int J Urol. 2013 Apr;20(4):413-9. doi: 10.1111/j.1442-2042.2012.03149.x. Epub 2012 Sep 12.

38.

Serum index test %[-2]proPSA and Prostate Health Index are more accurate than prostate specific antigen and %fPSA in predicting a positive repeat prostate biopsy.

Lazzeri M, Briganti A, Scattoni V, Lughezzani G, Larcher A, Gadda GM, Lista G, Cestari A, Buffi N, Bini V, Freschi M, Rigatti P, Montorsi F, Guazzoni G.

J Urol. 2012 Oct;188(4):1137-43. doi: 10.1016/j.juro.2012.06.017. Epub 2012 Aug 15.

PMID:
22901578
39.

Is erectile dysfunction a reliable proxy of general male health status? The case for the International Index of Erectile Function-Erectile Function domain.

Salonia A, Castagna G, Saccà A, Ferrari M, Capitanio U, Castiglione F, Rocchini L, Briganti A, Rigatti P, Montorsi F.

J Sex Med. 2012 Oct;9(10):2708-15. doi: 10.1111/j.1743-6109.2012.02869.x. Epub 2012 Aug 15.

PMID:
22897643
40.

Prostate saturation biopsy following a first negative biopsy: state of the art.

Maccagnano C, Gallina A, Roscigno M, Raber M, Capitanio U, Saccà A, Pellucchi F, Suardi N, Abdollah F, Montorsi F, Rigatti P, Scattoni V.

Urol Int. 2012;89(2):126-35. doi: 10.1159/000339521. Epub 2012 Jul 19. Review.

41.

Diagnosis and treatment of bladder endometriosis: state of the art.

Maccagnano C, Pellucchi F, Rocchini L, Ghezzi M, Scattoni V, Montorsi F, Rigatti P, Colombo R.

Urol Int. 2012;89(3):249-58. doi: 10.1159/000339519. Epub 2012 Jul 20. Review.

42.

Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy.

Gandaglia G, Suardi N, Gallina A, Abdollah F, Capitanio U, Salonia A, Colombo R, Bianchi M, Chun FK, Hansen J, Rigatti P, Montorsi F, Briganti A.

J Sex Med. 2012 Aug;9(8):2187-94. doi: 10.1111/j.1743-6109.2012.02812.x. Epub 2012 Jun 27.

PMID:
22738395
43.

Nerve-sparing approach during radical prostatectomy is strongly associated with the rate of postoperative urinary continence recovery.

Suardi N, Moschini M, Gallina A, Gandaglia G, Abdollah F, Capitanio U, Bianchi M, Tutolo M, Passoni N, Salonia A, Hedlund P, Rigatti P, Montorsi F, Briganti A.

BJU Int. 2013 May;111(5):717-22. doi: 10.1111/j.1464-410X.2012.11315.x. Epub 2012 Jun 21.

44.

National Comprehensive Cancer Network practice guidelines 2011: Need for more accurate recommendations for pelvic lymph node dissection in prostate cancer.

Abdollah F, Sun M, Suardi N, Gallina A, Capitanio U, Bianchi M, Tutolo M, Passoni N, Karakiewicz PI, Rigatti P, Montorsi F, Briganti A; National Comprehensive Cancer Network.

J Urol. 2012 Aug;188(2):423-8. doi: 10.1016/j.juro.2012.03.129. Epub 2012 Jun 13.

PMID:
22698627
45.

Leydig cell tumor of the spermatic cord in an adolescent affected by congenital adrenal hyperplasia.

Ferrari M, Raber M, Capitanio U, Russo G, Ferrario M, Rizzo N, Freschi M, Rigatti P, Montorsi F.

Int J Urol. 2012 Oct;19(10):954-6. doi: 10.1111/j.1442-2042.2012.03074.x. Epub 2012 Jun 13.

46.

Neoadjuvant short-term intensive intravesical mitomycin C regimen compared with weekly schedule for low-grade recurrent non-muscle-invasive bladder cancer: preliminary results of a randomised phase 2 study.

Colombo R, Rocchini L, Suardi N, Benigni F, Colciago G, Bettiga A, Pellucchi F, Maccagnano C, Briganti A, Salonia A, Rigatti P, Montorsi F.

Eur Urol. 2012 Nov;62(5):797-802. doi: 10.1016/j.eururo.2012.05.032. Epub 2012 May 18. Erratum in: Eur Urol. 2019 Mar;75(3):e81.

PMID:
22633362
47.

The extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma.

Capitanio U, Matloob R, Suardi N, Abdollah F, Castiglione F, Di Trapani D, Russo A, Briganti A, Carenzi C, Salonia A, Montorsi F, Rigatti P, Bertini R.

Urologia. 2012 Apr-Jun;79(2):109-15. doi: 10.5301/RU.2012.9255.

PMID:
22610843
48.

Presence of positive surgical margin in patients with organ-confined prostate cancer equals to extracapsular extension negative surgical margin. A plea for TNM staging system reclassification.

Abdollah F, Sun M, Suardi N, Gallina A, Capitanio U, Bianchi M, Tutolo M, Fossati N, Castiglione F, Freschi M, Karakiewicz P, Rigatti P, Montorsi F, Briganti A.

Urol Oncol. 2013 Nov;31(8):1497-503. doi: 10.1016/j.urolonc.2012.04.013. Epub 2012 May 15.

PMID:
22591746
49.

Serum sex steroids depict a nonlinear u-shaped association with high-risk prostate cancer at radical prostatectomy.

Salonia A, Abdollah F, Capitanio U, Suardi N, Briganti A, Gallina A, Colombo R, Ferrari M, Castagna G, Rigatti P, Montorsi F.

Clin Cancer Res. 2012 Jul 1;18(13):3648-57. doi: 10.1158/1078-0432.CCR-11-2799. Epub 2012 May 15.

50.

Perioperative betamethasone treatment reduces signs of bladder dysfunction in a rat model for neurapraxia in female urogenital surgery.

Castiglione F, Bergamini A, Bettiga A, Bivalacqua TJ, Benigni F, Strittmatter F, Gandaglia G, Rigatti P, Montorsi F, Hedlund P.

Eur Urol. 2012 Dec;62(6):1076-85. doi: 10.1016/j.eururo.2012.04.037. Epub 2012 Apr 19.

Supplemental Content

Loading ...
Support Center